HISTOlogic transfoRmatIon of EGFR-mutant lung Cancer in the real-world setting. HISTORIC study
Not Applicable
- Conditions
- on-small cell lung cancer with mutated EGFR
- Registration Number
- JPRN-UMIN000040448
- Lead Sponsor
- Wakayama medical university
- Brief Summary
In total, 6356 patients were enrolled. In 2624 patients, the histological type was proven by rebiopsy after acquiring resistance to EGFR-TKIs. Among them, 74 patients had HT (incidence rate: 2.8% [95% confidence interval: 2.3%-3.5%]).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 6356
Inclusion Criteria
Not provided
Exclusion Criteria
no criteria
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method